ArticleMiddle East African journal of ophthalmology
Applications of Artificial Intelligence in Choroid Visualization for Myopia: A Comprehensive Scoping Review.
Article in Middle East African journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Numerous artificial intelligence (AI) models, including deep learning techniques, are being developed to segment choroids in optical coherence tomography (OCT) images. However, there is a need for consensus on which specific models to use, requiring further synthesis of their efficacy and role in choroid visualization in myopic patients. A systematic literature search was conducted on three main databases (PubMed, Web of Science, and Scopus) using the search terms: "Machine learning" OR "Artificial Intelligence" OR "Deep learning" AND "Myopia" AND "Choroid" OR "Choroidal" from inception to February 2024 removing duplicates. A total of 12 studies were included. The populations included myopic patients with varying degrees of myopia. The AI models applied were primarily deep learning models, including U-Net with a bidirectional Convolutional Long Short-Term Memory module, LASSO regression, Attention-based Dense U-Net network, ResNeSt101 architecture training five models, and Mask Region-Based Convolutional Neural Network. The reviewed AI models demonstrated high diagnostic accuracy, including sensitivity, specificity, and area under the curve values, in identifying and assessing myopia-related changes. Various biomarkers were assessed, such as choroidal thickness, choroidal vascularity index, choroidal vessel volume, luminal volume, and stromal volume, providing valuable insights into the structural and vascular changes associated with the condition. The integration of AI models in ophthalmological imaging represents a significant advancement in the diagnosis and management of myopia. The high diagnostic accuracy and efficiency of these models underscore their potential to revolutionize myopia care, improving patient outcomes through early detection and precise monitoring of disease progression. Future studies should focus on standardizing AI methodologies and expanding their application to broader clinical settings to fully realize their potential in ophthalmology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.